Airway Hypocapnia Increases Microvascular Leakage in the Guinea Pig Trachea
- 1 January 1992
- journal article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 145 (1) , 80-84
- https://doi.org/10.1164/ajrccm/145.1.80
Abstract
We have previously shown that airway hypocapnia induced bronchoconstriction in the guinea pig lung by releasing tachykinins. To examine whether airway hypocapnia could also cause an increase in airway microvascular leakage, a tracheal segment was isolated in vivo in anesthetized guinea pigs and unidirectionally ventilated (200 ml/min) for 1 h with fully conditioned air (0% CO2) or isocapnic gas (5% CO2). The lungs were ventilated through a distally placed tracheal cannula. Microvascular leakage was quantitated by the injection of Evans blue (EB) and its extraction from the tracheal segment. EB extravasation was increased in tracheae exposed to 0% CO2 (52.3 +/- 2.0 micrograms/g wet tissue) compared with tracheae exposed to 5% CO2 (26.4 +/- 2.9 micrograms/g; p less than 0.05) and to tracheae from spontaneously breathing guinea pigs (25.2 +/- 2.3 micrograms/g; p less than 0.05). Groups of animals in which trachea were unidirectionally ventilated with 0% CO2 were then pretreated with a range of drugs in an attempt to determine the mediators responsible for the microvascular leakage with 0% CO2. Capsaicin and morphine pretreatment did not significantly alter 0% CO2-induced EB extravasation, and phosphoramidon prevented rather than increased extravasation, suggesting that tachykinins did not play a role. The hypocapnia-induced increase in microvascular leakage was, however, prevented by indomethacin pretreatment and significantly attenuated by dazmegrel, a thromboxane synthetase inhibitor. We conclude that airway hypocapnia causes microvascular leakage in the guinea pig trachea and that this effect is mediated by prostaglandins and/or thromboxane.Keywords
This publication has 15 references indexed in Scilit:
- Attenuation of the pulmonary vascular response to endotoxin by a thromboxane synthesis inhibitor (UK-38485) in unanesthetized sheepJournal of Surgical Research, 1991
- Inhibition of neutral endopeptidase potentiates neurogenic inflammation in the rat tracheaJournal of Applied Physiology, 1989
- Long-term Follow-up of Drug Abusers with Intravenous TalcosisAmerican Review of Respiratory Disease, 1989
- EFFECTS OF THROMBOXANE SYNTHETASE INHIBITOR (UK 38,485) AND THROMBOXANE RECEPTOR ANTAGONIST (ICI 185,282) ON DIGOXIN-INDUCED ARRHYTHMIAS IN ANAESTHETIZED GUINEA-PIGSClinical and Experimental Pharmacology and Physiology, 1988
- Specific Receptor and Cardiovascular Effects of Calcitonin Gene-Related Peptide*Endocrinology, 1986
- The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.Circulation, 1983
- Mediators of immediate hypersensitivityJournal of Allergy and Clinical Immunology, 1983
- Regulation of arachidonic acid production: role of phospholipases C and A2Trends in Pharmacological Sciences, 1982
- Regulatory Peptides in the Mammalian Respiratory Tract*Endocrinology, 1982
- Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicleProstaglandins, 1973